Form 8-K - Current report:
SEC Accession No. 0001823239-24-000124
Filing Date
2024-12-05
Accepted
2024-12-05 16:07:27
Documents
17
Period of Report
2024-12-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K mrvi-20241203.htm   iXBRL 8-K 39803
2 EX-10.1 ex101-mrvirsuagmt2024rsuae.htm EX-10.1 42558
3 EX-10.2 ex102-mrvirsuagmt2025rsuae.htm EX-10.2 41268
4 EX-99.1 ex991mrvipr-bodchairtransi.htm EX-99.1 11014
8 image_0.jpg GRAPHIC 2742
  Complete submission text file 0001823239-24-000124.txt   290996

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20241203.xsd EX-101.SCH 1782
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20241203_lab.xml EX-101.LAB 22548
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20241203_pre.xml EX-101.PRE 13046
19 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20241203_htm.xml XML 2833
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 241529147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)